Q1 2025 Alignment Healthcare Inc Earnings Call Transcript
Key Points
- Alignment Healthcare Inc (ALHC) reported a 32% year-over-year growth in health plan membership, reaching 217,500 members.
- The company achieved a 47% increase in total revenue, amounting to $927 million for the first quarter of 2025.
- Adjusted gross profit grew by 87% year over year, reaching $107 million, with a consolidated MVR improvement of 250 basis points.
- The company exceeded the high end of its first-quarter guidance with an adjusted IBEDA of $20 million, resulting in a 410 basis point margin expansion.
- ALHC is raising the midpoint of its guidance ranges across key metrics due to strong first-quarter results and solid growth momentum.
- Despite strong growth, ALHC still holds less than 5% market share across its existing markets.
- The company anticipates a reversal of early favorability in Part D growth margin over the next three quarters.
- ALHC expects its second half MBR to be higher than the first half due to normal utilization seasonality patterns and increased Part D liability.
- The company is investing in back-office operations and member engagement activities, which may impact short-term profitability.
- Thomas Freeman, the CFO, is stepping down, which could lead to transitional challenges as Jim Head takes over the role.
Good afternoon, and welcome to Alignment Healthcare's first-quarter 2025 earnings conference call and webcast. (Operator Instructions) Please note that this event is being recorded.
Leading today's call are John Kao, Founder and CEO; and Thomas Freeman, Chief Financial Officer.
Before we begin, we would like to remind you that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are subject to various risks and uncertainties and reflect our current expectations based on our beliefs, assumptions, and information currently available to us. Descriptions of some of the factors that could cause actual results that differ materially from these forward-looking statements are discussed in more detail in our filings with the SEC, including the risk factors section of our annual report on Form 10-K for the fiscal year ended December 31, 2024.
Although we believe our expectations are reasonable, we undertake no obligation to revise any statements to reflect changes that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
